Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila Medical Dialogues Bureau18 July 2019 3:47 AM GMT"Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
Natco Pharma gets zero USFDA observations for Chennai facility Medical Dialogues Bureau16 July 2019 4:00 AM GMTNatco Pharma announced "successful completion of regulatory inspection from the US Food and Drug Administration (USFDA) for its active pharmaceutical...
Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor Medical Dialogues Bureau9 July 2019 7:19 AM GMTMumbai: Sun Pharma Advanced Research Company (SPARC) on Monday said the US health regulator has given orphan drug designation to its novel kinase...
Zydus Cadila gets USFDA nod for generic Misoprostol tablets to treat ulcers Medical Dialogues Bureau5 July 2019 6:22 AM GMTNew Delhi: Drug firm Zydus Cadila Wednesday said it has received the final nod from the US health regulator to market its generic Misoprostol tablets...
Dr Reddys gets two USFDA observations for Vizag plants Farhat Nasim24 Jun 2019 5:39 AM GMTHyderabad: City-based Dr Reddy's Laboratories (Dr Reddys/ DRL) has reportedly fallen under the US health regulator's scanner. The company has been...
Cadila Healthcare gets EIR report on Ahmedabad SEZ facility Medical Dialogues Bureau18 Jun 2019 8:27 AM GMTNew Delhi: Drug firm Cadila Healthcare Monday said it has received establishment inspection report from the US health regulator with voluntary action...
Yes Bank reduces stake in Fortis Healthcare by selling shares worth over Rs 1.51 crore Farhat Nasim12 Jun 2019 5:59 AM GMTNew Delhi: Yes Bank has reduced its stake in Fortis healthcare (FHL) by around 2 per cent by selling over 1.51 crore shares of the company in various...
Natco Pharma- Kothur facility gets 9 observations from USFDA Medical Dialogues Bureau7 Jun 2019 8:51 AM GMTNEW DELHI: Natco Pharma Thursday said the US health regulator has made nine observations after the completion of inspection of its Kothur formulation...
GSK Consumers Healthcare gets shareholders' nod for merger with HUL Medical Dialogues Bureau3 Jun 2019 4:00 AM GMTEarlier in January, GlaxoSmithKline (GSK) Consumer Healthcare had informed that it has received approval from the fair trade regulator CCI for its...
Natco Pharma settles patent litigation with Onyx Therapeutics over anti cancer drug- Kyprolis Medical Dialogues Bureau1 Jun 2019 9:09 AM GMTNew Delhi: Natco Pharma Thursday said it has settled patent litigation with Onyx Therapeutics Inc in the US over a generic version of Kyprolis, an...
Natco Pharma settles patent litigation over generic version of anti-cancer drug Kyprolis Medical Dialogues Bureau30 May 2019 11:42 AM GMTKyprolis is the trade name for the generic drug Carfilzomib. The anti-cancer drug is a targeted therapy and is classified as a Proteasome Inhibitor....
Cadila Healthcare posts Q4 net profit of Rs 460 crore Medical Dialogues Bureau30 May 2019 3:45 AM GMTThe consolidated financial statements for the quarter and the year ended March 31, 2019, including the operations of Heinz India Pvt Ltd (HIPL) for...